© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to October
oral P2X3 ion channel antagonist
Ph. II, multiple settings (50-750 mg BID)
from literature P2X3 antagonists
Bayer AG, Berlin, DE
The Bayer P2X3 purinoreceptor antagonist, eliapixant (BAY1817080), is intended to treat various disorders associated with hypersensitive nerve fibers, including endometriosis. The hypothesis is that P2X3 receptor antagonism can inhibit cycles of…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.